• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Dominari Holdings Inc. Strengthens Team with Appointment of Experienced Accounting Team

    11/11/24 8:00:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $DOMH alert in real time by email

    Edward Deignan Appointed as VP of Finance and Accounting Kyle Degruttola Appointed as Controller

    NEW YORK, NY / ACCESSWIRE / November 11, 2024 / Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today announced that it has appointed Edward Deignan as Vice President of Finance and Accounting and Kyle Degruttola as Controller. Together, they bring decades of accounting and finance leadership experience from various multi-national and public sector organizations.

    Mr. Deignan is responsible for the day-to-day management of the Company's financial operations. He brings with him more than 30 years of experience in accounting, finance and banking. He has served as a chief financial officer for several companies over the past decade. He is a certified public accountant and holds a Bachelor of Science degree in accounting from Seton Hall University.

    Mr. Degruttola is responsible for directing all accounting operations. He brings with him more than 20 years of experience in accounting and finance, including serving as a collegiate professor of accounting and computer science at Wood Tobe-Coburn College and Union County College. Most recently, he served as Controller for the City of Jersey City. Prior to that, he served as the private equity accounting manager for US Retirement & Benefit Partners. He is a certified public accountant, a Series 27 financial and operations principal and holds a Bachelor of Science in accounting from Kean University.

    For additional information about Dominari Holdings Inc., please visit: https://www.dominariholdings.com/.

    About Dominari Holdings Inc.

    Dominari Holdings Inc. (the "Company"), formerly AIkido Pharma, Inc., was founded in 1967 as Spherix Incorporated. Since 2017, the Company operated as a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics and their related patent technology. The Company is in the process of winding down its historical pipeline of biotechnology assets held by Aikido Labs, LLC. In an effort to enhance shareholder value, in June of 2022, the Company formed a wholly owned financial services subsidiary, Dominari Financial Inc. ("Dominari Financial"), with the intent of shifting the Company's primary operating focus away from biotechnology to the fintech and financial services industries. Through Dominari Financial, the Company acquired Dominari Securities LLC ("Dominari Securities"), an introducing broker-dealer, registered with the Financial Industry Regulatory Authority ("FINRA") and an investment adviser registered with the Securities and Exchange Commission ("SEC"). Dominari Securities provides investment advisory services and annuity and insurance products of certain insurance carriers as an insurance agency through independent and affiliated brokers.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the SEC, which include but are not limited to the Risk Factors set forth in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2023 relating to its business. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

    Contacts:

    Dominari Holdings Inc.
    https://www.dominariholdings.com/

    Investor Relations
    Hayden IR
    Brett Maas, Managing Partner
    Phone: (646) 536-7331
    Email: [email protected]
    www.haydenir.com

    SOURCE: Dominari Holdings



    View the original press release on accesswire.com

    Get the next $DOMH alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DOMH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DOMH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ledwick Tim S bought 8,645 shares and was granted 10,000 shares, increasing direct ownership by 145% to 31,471 units (SEC Form 4)

    4 - Dominari Holdings Inc. (0000012239) (Issuer)

    2/12/25 5:03:10 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Lieberman Ronald J. bought 21,613 shares and was granted 10,000 shares (SEC Form 4)

    4 - Dominari Holdings Inc. (0000012239) (Issuer)

    2/12/25 5:00:46 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President Wool Kyle Michael bought 288,184 shares, increasing direct ownership by 15% to 2,200,769 units (SEC Form 4)

    4 - Dominari Holdings Inc. (0000012239) (Issuer)

    2/12/25 4:58:43 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOMH
    SEC Filings

    View All

    Dominari Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Dominari Holdings Inc. (0000012239) (Filer)

    9/22/25 8:05:34 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Holdings Inc. filed SEC Form 8-K: Leadership Update

    8-K - Dominari Holdings Inc. (0000012239) (Filer)

    9/10/25 8:00:30 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form S-3 filed by Dominari Holdings Inc.

    S-3 - Dominari Holdings Inc. (0000012239) (Filer)

    8/28/25 8:01:40 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOMH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dominari Holdings Announces Board Member Tim Ledwick to Assume Role of Interim Chief Financial Officer

    NEW YORK, Sept. 23, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH), today announced that Tim Ledwick, a current member of the Company's Board of Directors, has stepped down from the Board to serve as Interim Chief Financial Officer, beginning October 1, 2025. "Tim has extensive experience leading financial operations across multiple industries," said Anthony Hayes, Chief Executive Officer of Dominari Holdings. "His background spans public and private companies, with expertise in restructuring, capital markets, M&A, and operational turnarounds. As Interim Chief Finan

    9/23/25 8:00:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Securities Appoints Communications and Growth Strategist Brian Parsley to Board

    Accomplished entrepreneur and global speaker to strengthen firm's marketing, investor engagement and strategic communications to help drive growth NEW YORK, Sept. 10, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH), today announced the appointment of Brian Parsley to its Board of Directors. Parsley, an accomplished entrepreneur, behavioral analyst and internationally recognized speaker, will support the firm's growth by enhancing its marketing, investor outreach and overall communications strategy. Mr. Parsley has more than 30 years of experience in entrepreneurship,

    9/10/25 8:30:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Holdings Applauds American Bitcoin's Nasdaq Debut; Highlights Strategic Stake

    Dominari Holdings Inc. Holds Approximately 23,199,205 Shares of American Bitcoin (NASDAQ:ABTC), Valued at Approximately $170 Million at ABTC's September 5, 2025 Close NEW YORK, Sept. 9, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) ("Dominari" or the "Company") (NASDAQ:DOMH) today congratulated American Bitcoin ("ABTC") on its successful listing on the Nasdaq Stock Market. Dominari holds approximately 23,199,205 shares of ABTC. Based on ABTC's closing price of $7.40 per share on September 5, 2025, Dominari's position had an approximate market value of $171,674,117 at the time of that close.

    9/9/25 8:00:00 AM ET
    $ABTC
    $DOMH
    EDP Services
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOMH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Parsley Brian Keith

    3 - Dominari Holdings Inc. (0000012239) (Issuer)

    9/29/25 4:30:02 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Blattner Gregory James sold 14,409 shares, decreasing direct ownership by 39% to 22,411 units (SEC Form 4)

    4 - Dominari Holdings Inc. (0000012239) (Issuer)

    9/25/25 5:00:02 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CEO Hayes Anthony gifted 15,000 shares, decreasing direct ownership by 0.92% to 1,614,566 units (SEC Form 4)

    4 - Dominari Holdings Inc. (0000012239) (Issuer)

    5/6/25 4:15:04 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOMH
    Leadership Updates

    Live Leadership Updates

    View All

    Dominari Securities Appoints Communications and Growth Strategist Brian Parsley to Board

    Accomplished entrepreneur and global speaker to strengthen firm's marketing, investor engagement and strategic communications to help drive growth NEW YORK, Sept. 10, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH), today announced the appointment of Brian Parsley to its Board of Directors. Parsley, an accomplished entrepreneur, behavioral analyst and internationally recognized speaker, will support the firm's growth by enhancing its marketing, investor outreach and overall communications strategy. Mr. Parsley has more than 30 years of experience in entrepreneurship,

    9/10/25 8:30:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Holdings Set to Join Russell Microcap® Index

    NEW YORK, May 28, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH), is set to join the Russell Microcap® Index at the conclusion of the 2025 Russell indexes annual reconstitution, effective after the US market opens on June 30, according to a preliminary list of additions posted May 23. The annual Russell US Indexes reconstitution captures the 4,000 largest US stocks as of Wednesday, April 30, ranking them by total market capitalization. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth

    5/28/25 8:30:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Holdings Inc. Strengthens Team with Appointment of Experienced Accounting Team

    Edward Deignan Appointed as VP of Finance and Accounting Kyle Degruttola Appointed as Controller NEW YORK, NY / ACCESSWIRE / November 11, 2024 / Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today announced that it has appointed Edward Deignan as Vice President of Finance and Accounting and Kyle Degruttola as Controller. Together, they bring decades of accounting and finance leadership experience from various multi-national and public sector organizations.Mr. Deignan is responsible for the day-to-day management of the Company's financial operations. He brings with him more than 30 years of experience in accounting, finance and banking. He has served as a chief financial officer for s

    11/11/24 8:00:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOMH
    Financials

    Live finance-specific insights

    View All

    Dominari Holdings Announces Record Date for Cash Dividend

    NEW YORK, Aug. 22, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) is pleased to announce that its board of directors has authorized a special cash dividend of, in the aggregate, approximately $5 million, or $0.22 per share. The dividend is expected to be payable on or around September 26, 2025, to DOMH's shareholders and certain DOMH warrant holders (on an as-exercised basis) of record as of the close of business on September 3, 2025. For additional information about Dominari Holdings Inc., please visit: https://www.dominariholdings.com/ About Dominari Holdings Inc.

    8/22/25 9:15:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Marks Inflection Point with Second Quarter 2025 Financial Results

    Revenue of $34.1 Million, up 520%Closed 46 Transactions in Q2 with Total Raise Amount of More Than $288.9 Million between both our Private & Public TransactionsNEW YORK, Aug. 12, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH), today announced financial results for the quarter that ended June 30, 2025. The results underscore a significant inflection point for the Company, which delivered breakout performance during the quarter. "This quarter marks a turning point for Dominari," said Anthony Hayes, Chief Executive Officer of Dominari Holdings. "Revenue reached $34.1 m

    8/12/25 9:15:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Holdings Investment, American Data Centers, Becomes American Bitcoin in Transformative Bitcoin Mining Deal with Hut 8

    Dominari Executing Expansion Strategy with Investment in Industrial Scale Bitcoin Mining and Bitcoin Reserve Development  NEW YORK, March 31, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) today announced that American Data Centers Inc. ("ADC") and Hut 8 Corp, ("Hut") partnered to form American Bitcoin Corporation.  As previously announced, ADC was a wholly owned subsidiary of Dominari, but became an independent company, whose members include Donald J. Trump Jr., Eric Trump, Dominari and other industry professionals in the AI space.  In partnership with Hut, American Bitcoin Corp., will focus on industrial-scale bitcoin mining and strategic bitcoin reserve development and monetiza

    3/31/25 8:00:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOMH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Dominari Holdings Inc.

    SC 13D/A - Dominari Holdings Inc. (0000012239) (Subject)

    6/13/24 8:56:04 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Dominari Holdings Inc.

    SC 13D/A - Dominari Holdings Inc. (0000012239) (Subject)

    6/13/24 4:32:07 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care